Continuous Positive Airway Pressure Therapy on Nonalcoholic Fatty Liver Disease in Patients With Obstructive Sleep Apnea
Explore this paper's citation graph
Summary
OSA treatment with CPAP was associated with significant biochemical improvement and reduction in NAFLD-related fibrosis and was an independent predictor of regression of sNAFLD after adjusting for obesity class and severity of OSA.
- Type
- article
- Published
- 2018-08-15
- Cited by
- 32
- References
- 49
- Access
- Open access
- OpenAlex
- https://openalex.org/W2885926029
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:51954462
Keywords
Medicine, Continuous positive airway pressure, Obstructive sleep apnea, Nonalcoholic fatty liver disease, Sleep (system call)
References
- Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study.
- Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults.
- Obstructive sleep apnea: a cardiometabolic risk in obesity and the metabolic syndrome.
- STRIDE - An Integrated Standards-Based Translational Research Informatics Platform
- Liver Steatosis and Fibrosis in OSA patients After Long-term CPAP Treatment: A Preliminary Ultrasound Study.
- Impacts of long-term CPAP therapy on fatty liver in male OSA patients with abdominal obesity
- Mechanisms of vascular damage in obstructive sleep apnea
- Continuous Positive Airway Pressure and Liver Enzymes in Obstructive Sleep Apnoea: Data from a Randomized Controlled Trial
- Association between Non-invasive Fibrosis Markers and Mortality among Adults with Non-alcoholic Fatty Liver Disease in the United States
- Elevated serum alanine aminotransferase and gamma-glutamyltransferase and mortality in the United States population.
- Effects of obstructive sleep apnea syndrome on hepatic steatosis and nonalcoholic steatohepatitis.
- A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C
- Chronic intermittent hypoxia predisposes to liver injury
- Obstructive Sleep Apnea Is Associated with Fatty Liver and Abnormal Liver Enzymes: a Meta-analysis
- A Novel Animal Model of Nonalcoholic Steatohepatitis (NASH): Hypoxemia Enhances the Development of NASH
- Chronic intermittent hypoxia is a major trigger for non-alcoholic fatty liver disease in morbid obese.
- Continuous Positive Airway Pressure Improves Sleep Apnea Associated Fatty Liver
- Chronic liver injury during obstructive sleep apnea
- Hypoxia aggravates non-alcoholic steatohepatitis in mice lacking hepatocellular PTEN.
- The Role of Continuous Positive Airway Pressure in Blood Pressure Control for Patients With Obstructive Sleep Apnea and Hypertension: A Meta‐Analysis of Randomized Controlled Trials
Cited by
- Obstructive sleep apnoea and comorbidity – an overview of the association and impact of continuous positive airway pressure therapy
- Obstructive Sleep Apnea and the Liver
- Extra-hepatic manifestations and complications of nonalcoholic fatty liver disease.
- Intermittent hypoxia, energy expenditure, and visceral adipocyte recovery.
- Non-alcoholic fatty liver disease in adults: Current concepts in etiology, outcomes and management.
- Association between non-alcoholic fatty liver disease and obstructive sleep apnea
- Sleep disorder in patients with chronic liver disease: a narrative review
- Hypoxia and Non-alcoholic Fatty Liver Disease
- Clinical assessment and management of liver fibrosis in non-alcoholic fatty liver disease
- Evaluation and management of extrahepatic manifestations of nonalcoholic fatty liver disease
- Non-alcoholic fatty liver disease as metabolic consequence of obstructive sleep apnea
- Comprehensive Overview of Sleep Disorders in Patients with Chronic Liver Disease
- The Assessment of Sleep Quality in Patients Following Valve Repair and Valve Replacement for Infective Endocarditis: A Retrospective Study at a Single Center
- Metabolic dysfunction in OSA: Is there something new under the sun?
- Impact of continuous positive airway pressure therapy for nonalcoholic fatty liver disease in patients with obstructive sleep apnea
- The Snoring Index Identifies Risk of Non-Alcoholic Fatty Liver Disease in Patients with Obstructive Sleep Apnea Syndrome
- Obstructive sleep apnea, intermittent hypoxia and non-alcoholic fatty liver disease.
- Management of non-alcoholic fatty liver disease patients with sleep apnea syndrome
- Association Between Metabolic-Associated Fatty Liver Disease and Obstructive Sleep Apnea: A Cross-Sectional Study
- Premature mortality with gout and hyperuricemia may be reduced by early resolution of comorbid obstructive sleep apnea
Related papers
- OBSTRUCTIVE SLEEP APNEA: TITRATE OR NOT TITRATE?
- Effectiveness of continuous positive airway pressure in lowering blood pressure in patients with obstructive sleep apnea: a critical review of the literature
- [Beneficial effect of continuous positive airway pressure therapy in obstructive sleep apnea syndrome].
- Is There a Role for Continuous Positive Airway Pressure Treatment in the Management of Obstructive Sleep Apnea-related Hypertension?
- [Investigation on long-term efficacy of CPAP treatment for the elderly with obstructive sleep apnea syndrome].
- Continuous positive airway pressure for obstructive sleep apnea.